Terms: = Brain cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
202 results:
1. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
[TBL] [Abstract] [Full Text] [Related]
2. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
Liu Z; Wang S; Yu K; Chen K; Zhao L; Zhang J; Dai K; Zhao P
J Transl Med; 2023 Nov; 21(1):863. PubMed ID: 38017538
[TBL] [Abstract] [Full Text] [Related]
3. Comparative Analysis of the Embryonal brain Tumors Based on Their Molecular Features.
Shcherbina V; Kovalevska L; Pedachenko E; Malysheva T; Kashuba E
Discov Med; 2023 Oct; 35(178):733-749. PubMed ID: 37811612
[TBL] [Abstract] [Full Text] [Related]
4. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
5. myc up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma.
Pitolli C; Marini A; Guerra M; Pieraccioli M; Marabitti V; Palluzzi F; Giacò L; Tamburrini G; Cecconi F; Nazio F; Sette C; Pagliarini V
J Exp Clin Cancer Res; 2023 Aug; 42(1):214. PubMed ID: 37599362
[TBL] [Abstract] [Full Text] [Related]
6. EYA2 tyrosine phosphatase inhibition reduces myc and prevents medulloblastoma progression.
Wolin AR; Vincent MY; Hotz T; Purdy SC; Rosenbaum SR; Hughes CJ; Hsu JY; Oliphant MUJ; Armstrong B; Wessells V; Varella-Garcia M; Galbraith MD; Pierce A; Wang D; Venkataraman S; Danis E; Veo B; Serkova N; Espinosa JM; Gustafson DL; Vibhakar R; Ford HL
Neuro Oncol; 2023 Dec; 25(12):2287-2301. PubMed ID: 37486991
[TBL] [Abstract] [Full Text] [Related]
7. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
8. Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M; Vennarini S; Buttarelli FR; Antonelli M; Colombo F; Minasi S; Pecori E; Ferroli P; Giussani C; Schiariti M; Schiavello E; Biassoni V; Erbetta A; Chiapparini L; Nigro O; Boschetti L; Gianno F; Miele E; Modena P; De Cecco L; Pollo B; Barretta F
J Neurooncol; 2023 Jul; 163(3):577-586. PubMed ID: 37326761
[TBL] [Abstract] [Full Text] [Related]
9. Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in cancer Stem Cells.
Lee H; Ha S; Choi S; Do S; Yoon S; Kim YK; Kim WY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298484
[TBL] [Abstract] [Full Text] [Related]
10. Upregulation of the Oct3/4 Network in Basal Breast cancer Is Associated with Its Metastatic Potential and Shows Tissue Dependent Variability.
Rajan RG; Krutilina RI; Ignatova TN; Pavicevich ZS; Dulatova GM; Lane MA; Chatterjee AR; Rooney RJ; Antony M; Hagerty VR; Kukekov NV; Hanafy KA; Vrionis FD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298091
[TBL] [Abstract] [Full Text] [Related]
11. NAA10 overexpression dictates distinct epigenetic, genetic, and clinicopathological characteristics in adult gliomas.
Le MK; Vuong HG; Nguyen TTT; Kondo T
J Neuropathol Exp Neurol; 2023 Jun; 82(7):650-658. PubMed ID: 37253389
[TBL] [Abstract] [Full Text] [Related]
12. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway.
Wang Y; Gao G; Wei X; Zhang Y; Yu J
Drug Des Devel Ther; 2023; 17():1357-1369. PubMed ID: 37181827
[TBL] [Abstract] [Full Text] [Related]
13. Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.
Han W; Chen L
Mol Carcinog; 2023 Jul; 62(7):975-990. PubMed ID: 37036189
[TBL] [Abstract] [Full Text] [Related]
14. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract] [Full Text] [Related]
15. Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering myc amplification and genomic instability.
Luo Z; Xin D; Liao Y; Berry K; Ogurek S; Zhang F; Zhang L; Zhao C; Rao R; Dong X; Li H; Yu J; Lin Y; Huang G; Xu L; Xin M; Nishinakamura R; Yu J; Kool M; Pfister SM; Roussel MF; Zhou W; Weiss WA; Andreassen P; Lu QR
Nat Commun; 2023 Feb; 14(1):762. PubMed ID: 36765089
[TBL] [Abstract] [Full Text] [Related]
16. Metabolic rewiring in myc-driven medulloblastoma by BET-bromodomain inhibition.
Graziani V; Garcia AR; Alcolado LS; Le Guennec A; Henriksson MA; Conte MR
Sci Rep; 2023 Jan; 13(1):1273. PubMed ID: 36690651
[TBL] [Abstract] [Full Text] [Related]
17. Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.
Luo Z; Xia M; Shi W; Zhao C; Wang J; Xin D; Dong X; Xiong Y; Zhang F; Berry K; Ogurek S; Liu X; Rao R; Xing R; Wu LMN; Cui S; Xu L; Lin Y; Ma W; Tian S; Xie Q; Zhang L; Xin M; Wang X; Yue F; Zheng H; Liu Y; Stevenson CB; de Blank P; Perentesis JP; Gilbertson RJ; Li H; Ma J; Zhou W; Taylor MD; Lu QR
Nature; 2022 Dec; 612(7941):787-794. PubMed ID: 36450980
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Woo HY; Chae SW; DO SI; Na K
Anticancer Res; 2022 Nov; 42(11):5601-5608. PubMed ID: 36288864
[TBL] [Abstract] [Full Text] [Related]
19. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract] [Full Text] [Related]
20. An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-myc and S100A16.
Ma L; Li G; Yang T; Zhang L; Wang X; Xu X; Ni H
Cancer Chemother Pharmacol; 2022 Dec; 90(6):431-444. PubMed ID: 36224471
[TBL] [Abstract] [Full Text] [Related]
[Next]
